menu
    • menu
    [{"orgOrder":0,"company":"EV\u014cQ Nano","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Genetic Disease","country":"U.S.A","productType":"Other Small Molecule","year":"2024","type":"Inapplicable","leadProduct":"EVQ-218","moa":"Undisclosed","graph1":"Genetic Disease","graph2":"IND Enabling","graph3":"EV\u014cQ Nano","amount2":0,"highestDevelopmentShortName":"IND","therapeuticAreaShortName":"Genetic Disease","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"EV\u014cQ Nano \/ Inapplicable","highestDevelopmentStatusID":"5","companyTruncated":"EV\u014cQ Nano \/ Inapplicable"}]

    Find Clinical Drug Pipeline Developments & Deals by EVŌQ Nano

    Menu

    EVŌQ Nano

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            EVŌQ Nano

                            U.S.A arrow
                            CRS
                            Not Confirmed

                            EVŌQ Nano

                            U.S.A arrow
                            CRS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : EVQ-218

                            Therapeutic Area : Genetic Disease

                            Study Phase : IND Enabling

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            EVŌQ Bio Completes Pre-IND Meeting with FDA for Inhaled Therapeutic for Lung Infections

                            Details : EVQ-218 is a stable, non-ionic silver nanoparticle that can effectively kill a range of problematic bacteria. It is being evaluated for the treatment of cystic fibrosis and other lung diseases.

                            Product Name : EVQ-218

                            Product Type : Other Small Molecule

                            Upfront Cash : Inapplicable

                            May 15, 2024

                            Lead Product(s) : EVQ-218

                            Therapeutic Area : Genetic Disease

                            Highest Development Status : IND Enabling

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth